Other: — Antineoplastic and immunosuppressive medicaments: — Containing hydroxyurea or cyclophosphamide or their salts
Part of: 30049092 — Other
N361639 · 2026-05-26 — The tariff classification of Nintedanib Capsules in dosage form, from India
Nintedanib imported in 100 mgand 150 mg capsules, is in a class of medications called Tyrosine Kinase, Inhibitor (TKI)It is indicated for the treatment of adults with idiopathic pulmonary fibrosis (IPF), and. chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype.The applicable subheading for the Nintedanib Capsules in dosage form will be 3004.90.9216, HarmonizedTariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed orunmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or…
N359426 · 2026-04-01 — The tariff classification of Dasatinib Tablets in dosage form, from India
Dasatinib, imported in 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg tablets, is in a class of medications called antineoplastic tyrosine kinase inhibitors. It is indicated for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia. The applicable subheading for the Dasatinib Tablets in dosage form will be 3004.90.9216, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments… consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for…
N359387 · 2026-04-01 — The tariff classification of Tofacitinib Tablets in dosage form, from India
Tofacitinib, imported in tablet form (5 mg and 10 mg) and in extended-release tablets (11 mg and 22 mg), is a medicinal preparation containing Tofacitinib Citrate, a Janus kinase (JAK) inhibitor, as the active ingredient. It is indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis. The applicable subheading for the Tofacitinib Tablets in dosage form will be 3004.90.9216, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or…
N355845 · 2025-11-28 — The tariff classification of Metoprolol Succinate Extended-Release Tablets in dosage form, from Spain
Metoprolol Succinate, imported in 25 mg, 50 mg, 100 mg and 200 mg extended-release tablets, is a selective ß1 receptor blocker. It is indicated for the treatment of hypertension, angina pectoris and heart failure. The applicable subheading for the Metoprolol Succinate Extended-Release Tablets in dosage form will be 3004.90.9216, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments… consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other:…
H312361 · 2023-08-21 — Revocation of NY N276739 and HQ 957022; Classification of sodium bicarbonate cartridges/bags
This is in reference to New York Ruling Letter (NY) N276739, issued to you by U.S. Customs and Border Protection (CBP) on July 12, 2016, concerning classification of a “Bibag” from France, under the Harmonized Tariff Schedule of the United States (HTSUS). We have reviewed that decision, and determined that it is incorrect, and for the reasons set forth below, are revoking your ruling. We have also reviewed Headquarters Ruling (HQ) 957022, dated January 24, 1995, and for similar reasons set forth below, are revoking that ruling. Pursuant to section 625(c)(1), Tariff Act of 1930 (19 U.S.C.…
Not sure this code fits your product? HaiLang AI determines the US HTS code from a description in about a minute.
Classify a product